Heidelberg Pharma AG
XHAM:HPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Heidelberg Pharma AG
XHAM:HPHA
|
DE |
|
Nepi Rockcastle NV
F:0A3
|
NL |
|
S
|
Smith Micro Software Inc
SWB:SS91
|
US |
|
P
|
Public Service Enterprise Group Inc
DUS:PSE
|
US |
|
HBT Financial Inc
F:9ND
|
US |
|
E
|
Electronic Arts Inc
SWB:ERT
|
US |
|
C
|
CAP SA
SGO:CAP
|
CL |
|
O
|
Opera Ltd
F:2V8
|
NO |
|
Cyber_Folks SA
F:0K0
|
PL |
|
Shanghai Electric Group Co Ltd
OTC:SIELF
|
CN |
|
D
|
DigitalOcean Holdings Inc
XBER:0SU
|
US |
|
G
|
Gap Inc
F:GAP
|
US |
|
N
|
NetApp Inc
DUS:NTA
|
US |
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
US |
|
M
|
Mitsui Chemicals Inc
XMUN:MSI
|
JP |
|
Ideal Power Inc
NASDAQ:IPWR
|
US |
|
M
|
Main Street Capital Corp
F:13M
|
US |
|
O
|
Ollie's Bargain Outlet Holdings Inc
F:OL6
|
US |
|
H
|
Heidelberg Pharma AG
DUS:HPHA
|
DE |
Wall St Price Targets
HPHA Price Targets Summary
Heidelberg Pharma AG
According to Wall Street analysts, the average 1-year price target for HPHA is 5.5 EUR with a low forecast of 5.45 EUR and a high forecast of 5.67 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HPHA's stock price target?
Price Target
5.5
EUR
According to Wall Street analysts, the average 1-year price target for HPHA is 5.5 EUR with a low forecast of 5.45 EUR and a high forecast of 5.67 EUR.
What is the Revenue forecast for Heidelberg Pharma AG?
Projected CAGR
202%
Over the last 9 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 202%.
What is the Gross Profit forecast for Heidelberg Pharma AG?
Projected CAGR
26%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 5 years is 26%.
